Registration - In-house Corporation

Subject Matters

• Health
• Industry
• Intellectual Property
• Internal Trade
• International Trade

Subject Matter Details

Legislative Proposal, Bill or Resolution

• Industry Canada regarding export provisions of the Patent Act.
• Industry Canada with respect to the Patent Act as it pertains to pharmaceuticals.
• Modernization of the Food and Drug Act (formerly Bill C-51) with respect to the development and implementation of a Progressive Licensing Framework for pharmaceuticals.

Policies or Program

• Health Canada regarding the need for appropriate, dedicated resources for the Therapeutic Products Directorate to meet performance targets for the review of generic drug submissions.
• Health Canada, Industry Canada, and International Trade Canada regarding effective measures to combat counterfeit drugs in Canada and around the world.
• Science and Technology Strategy regarding the need for a balanced Intellectual Property (IP) regime and the important role competition plays in encouraging innovation.
• The development and implementation of an approval pathway for Subsequent Entry Biologics (SEBs).

Regulation

• Amendments to the Patented Medicines (Notice of Compliance) Regulations with regard to section 8 of the regulations, the inclusion of a mechanism that would prevent a brand company from suing a generic company twice on the same patent and an administrative change to explicitly allow a generic company to amend a Notice of Allegation.

Communication Techniques

• Written communication
• Oral communication

Government Institutions

• Canadian Heritage (PCH)
• Health Canada (HC)
• House of Commons
• Industry Canada
• Patented Medicine Prices Review Board (PMPRB)
• Prime Minister's Office (PMO)
• Senate of Canada

Address:
6733 Mississauga Road, Suite 400
Mississauga, ON  L5N 6J5
Canada

Telephone number: 905-814-1820
Fax number: 905-814-8696  

Parent Company Information